SELLAS Life Sciences Group, Inc.SLSNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, slight contraction.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-35.40M
↓ 22% below average
Average (9y)
$-28.93M
Historical baseline
Range
High:$-10.42M
Low:$-48.31M
CAGR
-3.4%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-35.40M | +4.1% |
| 2023 | $-36.91M | -30.4% |
| 2022 | $-28.31M | -8.8% |
| 2021 | $-26.02M | -149.8% |
| 2020 | $-10.42M | +41.0% |
| 2019 | $-17.64M | +42.0% |
| 2018 | $-30.42M | -176.8% |
| 2017 | $-10.99M | +75.5% |
| 2016 | $-44.92M | +7.0% |
| 2015 | $-48.31M | - |